New product strategy

 

 

Focusing on the four key areas, combined with the Group's existing product lines and production lines, we will screen varieties with high clinical value and good market prospects, and reserve varieties to enhance Jingfeng's future market competitiveness.

​○ Speed​○ Business​○ Service

Platform construction

Build two national new product research and development and process innovation platforms for diabetes and external drugs

R&D model

Chemical medicine is the mainstay, supplemented by traditional Chinese medicine; Imitation and imitation are the mainstay, and the first imitation is supplemented

Choose the opportunity to enter innovative drugs

Breed selection

Priority is given to raw material matching, channel support, and centralized procurement varieties

Research and development process

 

New drug project

 

Feasibility analysis report

Project decision-making

Project approval

 

Technical study

 

Prescription process optimization

Prescription amplification study

Process research report

PROC

 

​Quality research

 

Method development and establishment

Methodological validation

Method validation report

quality standard

 

Process validation

 

Validation scheme

Validation report

batch manufacturing records

 

Registration declaration

 

Declaration of information

on-site verification

 

​Declaration approved

 

Supplementary information

Production approval certificate

​Service platform

 

Research and development + production

One-system efficient

 

Production and commercialization go hand in hand

 

Customized service

 

API &FDF are kept in parallel

 

Complete production line

扫描二维码分享到微信